Comparison between intact and bioactive parathyroid hormone assays in patients with severe heart failure.

Clin Biochem

Pôle de Recherche en Endocrinologie, Diabète et Nutrition, Institut de Recherche Expérimentale et Clinique, Cliniques Universitaires St-Luc and Université Catholique de Louvain, Brussels, Belgium.

Published: March 2013

Objectives: Parathyroid hormone (PTH) is a major systemic calcium-regulating hormone. Recent evidence has suggested that measurement of PTH might provide complementary information for the diagnosis and risk stratification of patients with heart failure (HF). The aim of our study was to compare intact and bioactive PTH assays in patients with severe heart failure.

Design And Methods: The following measurements were carried out in blood samples from 73 patients with severe heart failure: bioactive PTH (1-84) assay, intact PTH assay, non-PTH (1-84), 25-hydroxyvitamin D, B-type natriuretic peptide (BNP), N-terminal proBNP (Nt-proBNP), Galectin-3 and high sensitive troponin T (hsTnT).

Results: The correlation between intact and bioactive PTH assays was very high in HF patients. However, the bioactive PTH concentrations were lower than those measured with the intact assay. Intact and bioactive PTH as well as non-PTH (1-84) was significantly and positively correlated to BNP, Nt-proBNP, and galectin-3 but not to hsTnT. The strongest relationships with these cardiac biomarkers and with cardiovascular death were observed with the bioactive PTH assay.

Conclusions: The PTH concentrations obtained with intact and bioactive assays are not comparable in patients with severe HF. The specificity of PTH assays might therefore impact on the potential diagnosis and prognosis values of PTH testing in patients with heart failure.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinbiochem.2012.12.002DOI Listing

Publication Analysis

Top Keywords

bioactive pth
24
intact bioactive
20
patients severe
16
heart failure
16
severe heart
12
pth
12
pth assays
12
bioactive
8
parathyroid hormone
8
assays patients
8

Similar Publications

FDA-approved polypeptide PTH 1-34 impedes palmitic acid-mediated osteoblasts dysfunction by promoting its differentiation and thereby improving skeletal health.

Mol Cell Endocrinol

February 2025

Division of Endocrinology, CSIR-Central Drug Research Institute, Lucknow, UP, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India. Electronic address:

Excessive consumption of saturated fatty acids creates a debilitating cellular environment that hinders the normal function and survival of osteoblasts, contributing to bone metabolic disorders such as osteoporosis. The FDA-approved polypeptide PTH 1-34 is a well-established therapy for post-menopausal osteoporosis, yet its protective effects in a palmitic acid (PA)-rich hyperlipidemic environment are not well understood. This study investigates the impact of PTH 1-34 on PA-induced cellular responses in osteoblasts.

View Article and Find Full Text PDF

Secretion of the human parathyroid hormone through a microcin type I secretion system in Escherichia coli.

Microb Cell Fact

October 2024

Sección Fisiología y Genética Bacterianas, Facultad de Ciencias, Montevideo, Uruguay.

Background: Gram negative bacteria possess different secretion systems to export proteins to the extracellular medium. The simplest one, type I secretion system (T1SS), forms a channel across the cell envelope to export proteins in a single step. Peptides secreted by the T1SSs comprise a group of antibiotics, called class II microcins, which carry an amino terminal secretion domain that is processed concomitantly with export.

View Article and Find Full Text PDF

An increase in plant-sourced (PS) nutrient intake is promoted in support of a sustainable diet. PS dietary minerals and proteins have bioactive properties that can affect bone health and the risk of fracture. In a group randomised, cross-over design, this study evaluated the post-ingestion temporal pattern of change in arterialised ionised calcium (iCa), parathyroid hormone (PTH), -terminal crosslinked telopeptide of type I collagen (CTX) and procollagen type 1 amino-terminal propeptide (P1NP) for 4 h following ingestion of a novel supplement (SUPP) containing a PS marine multi-mineral + PS protein isolate.

View Article and Find Full Text PDF

Unraveling the benefits of DSM 29784 poultry probiotic through its secreted metabolites: an approach.

Microbiol Spectr

November 2024

European Laboratory of Innovation Science & Expertise (ELISE). Adisseo France S.A.S., Saint Fons, France.

Article Synopsis
  • The probiotic 29784 (Bs29784) supports chicken intestinal health by producing metabolites like hypoxanthine, niacin, and pantothenate, enhancing resilience and performance through immune response, barrier function, and microbiota modulation.
  • Experimental models showed that Bs29784 vegetative cells significantly reduced inflammation and improved intestinal integrity better than spores, while individual metabolites had distinct positive effects on inflammation and cell growth.
  • Fermentation studies revealed that different metabolites influenced the microbiota and fermentation profiles, with specific compounds like PTH and HPX enhancing epithelial resilience and overall intestinal health.
View Article and Find Full Text PDF

Polyetheretherketone (PEEK) is a high-performance polymer suitable for use in biomedical coatings. The implants based on PEEK have been extensively studied in dental and orthopedic fields. However, their inherent inert surfaces and poor osteogenic properties limit their broader clinical applications.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!